Answers are grounded in this paper and cite their sources.
Introduction: Alzheimer's disease (AD) is one of the most prevalent neurodegenerative disorders, characterized by progressive memory loss and cognitive decline, ultimately leading to dementia.Currently, there is no definitive cure, and available treatments focus only on alleviating symptoms and slowing disease progression.In recent years, nanomedicine has been proposed as a potential approach for the treatment of various diseases, including AD. Nanotechnology offers novel solutions to key challenges in AD treatment, such as poor drug solubility in biological fluids, low bioavailability, limited ability to cross the blood-brain barrier (BBB), and rapid drug metabolism.This systematic review describes the potential applications and benefits of nanoparticles in the fight against AD.Materials and Methods: To achieve the study's objectives, a comprehensive literature search was conducted across reputable databases, covering publications from 1990 to November 2024.The search included keywords related to AD, its diagnosis, and treatment.Results: The findings suggest that nanoparticles can enhance the effectiveness of existing AD treatments by improving drug solubility, increasing bioavailability, and facilitating drug transport across the BBB.These properties suggest that nanoparticles could be promising tools for more effective AD management.Conclusion: Advances in nanomedicine offer significant opportunities for the development of innovative therapeutic approaches for AD.By improving drug delivery and treatment efficacy, nanoparticles could contribute to early detection and better disease management.
No takes yet. Share an insight, caveat, or question.
Zare et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: